Our Pricing

Weight Loss Injection Prescription UK: Complete Clinical Guide

Published on: June 03, 2026

Getting a weight loss injection prescription UK has never been more accessible. At Cured Pharmacy, our UK-registered clinical team provides free online consultations under 3 minutes, prescribing genuine MHRA-licensed treatments including Mounjaro, Wegovy, and Saxenda with transparent upfront pricing and discreet home delivery.

How Weight Loss Injection Prescriptions Work in the UK

All prescription weight loss injections in the UK require clinical assessment by a GPhC-registered prescriber before dispensing. At Cured Pharmacy, this process takes under 3 minutes through our secure online consultation platform, where you'll answer medical history questions reviewed by our UK clinical team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

Once approved, your prescription is dispensed from our UK-registered pharmacy (GPhC 9012511) and delivered discreetly to your door. We only supply genuine UK-licensed medications approved by the MHRA, ensuring you receive the same quality treatments available through traditional healthcare pathways [1].

Your prescriber will assess your BMI, medical history, current medications, and weight loss goals to determine the most appropriate treatment. This individualised approach ensures safety and optimises clinical outcomes whilst complying with NICE guidelines for weight management interventions [2].

Who Qualifies for Weight Loss Injection Prescriptions?

NICE guidelines recommend prescription weight loss medications for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related health conditions such as type 2 diabetes, hypertension, or obstructive sleep apnoea [2]. Your UK prescriber will verify eligibility during your clinical assessment and may request additional information if your medical history requires closer evaluation.

Mounjaro (Tirzepatide): Dual-Action Weight Loss Injection

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management. This innovative mechanism activates two natural hormone pathways simultaneously, producing superior weight reduction compared to single-pathway alternatives [3].

In the SURMOUNT-1 clinical trial, participants receiving the highest tirzepatide dose achieved an average 22.5% body weight reduction over 72 weeks — significantly outperforming semaglutide in head-to-head comparisons [3]. Patients typically start on a 2.5mg weekly dose, gradually increasing to therapeutic levels of 5mg, 10mg, or 15mg based on individual response and tolerability.

Mounjaro is administered once weekly via a pre-filled KwikPen injector, designed for subcutaneous injection into the abdomen, thigh, or upper arm. The pen features a hidden needle and simple push-button mechanism, making self-administration straightforward even for injection-naïve patients. At Cured Pharmacy, Mounjaro is available from £135.00 following prescriber approval.

Wegovy (Semaglutide): Clinically Proven GLP-1 Treatment

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1 to regulate appetite and food intake. The STEP clinical trial programme demonstrated an average 14.9% body weight reduction over 68 weeks in adults with obesity [4].

Administered once weekly via pre-filled pen, Wegovy follows a gradual dose escalation schedule starting at 0.25mg and increasing to the maintenance dose of 2.4mg over 16-20 weeks. This titration approach minimises gastrointestinal side effects whilst optimising therapeutic response [4].

Wegovy has been available at Cured Pharmacy with competitive UK pricing, offering patients an established treatment option backed by extensive real-world evidence. The medication requires refrigeration before first use and can be stored at room temperature for up to 28 days once in use.

Wegovy Oral Tablets: New Formulation Available

Cured Pharmacy now offers Wegovy oral tablets (semaglutide pill) on pre-order, providing a needle-free alternative for patients who prefer oral administration. This formulation delivers the same active ingredient as the injection, offering flexibility in treatment choice whilst maintaining clinical efficacy. Pricing starts from £135.00 subject to prescriber approval.

Saxenda (Liraglutide): Daily Weight Management Injection

Saxenda contains liraglutide, a GLP-1 receptor agonist administered daily rather than weekly. Clinical trials showed an average 8% body weight reduction over 56 weeks when combined with reduced-calorie diet and increased physical activity [5].

The daily dosing schedule provides consistent appetite suppression throughout the week, which some patients prefer over weekly injections. Saxenda is titrated from 0.6mg daily up to the maintenance dose of 3mg over five weeks, allowing your body to adjust gradually to the medication [5].

Available from £135.00 at Cured Pharmacy, Saxenda offers an established treatment option for patients seeking daily injection therapy. The pre-filled pen delivers 30 days of treatment at the maintenance dose and uses a fine needle for comfortable subcutaneous administration.

Orlistat-Based Treatments: Non-Injection Weight Loss Options

For patients who prefer oral medication over injections, Cured Pharmacy offers several orlistat-based treatments including prescription-strength Orlistat 120mg, Xenical, and lower-dose options like Alli 60mg and Orlos 60mg. Orlistat works by blocking approximately 25% of dietary fat absorption in the intestines [6].

Unlike GLP-1 injections that work centrally to reduce appetite, orlistat acts locally in the digestive system and requires adherence to a reduced-fat diet for optimal results. Clinical trials demonstrated an average 5-10% body weight reduction over 12 months when combined with lifestyle modifications [6].

Prescription-strength Orlistat 120mg starts from £135.00, whilst Xenical (branded orlistat) is available from £135.00. Lower-dose formulations like Alli and Orlos are suitable for patients with lower BMI thresholds and provide a stepping-stone approach to weight management.

Choosing Between Injection and Oral Treatments

Your UK prescriber will discuss the benefits and limitations of each treatment type during your consultation. Injectable GLP-1 medications typically produce greater weight reduction but require weekly or daily injections, whilst oral orlistat offers convenience without needles but requires strict dietary fat restriction. The choice depends on your medical history, weight loss goals, lifestyle preferences, and clinical suitability.

Why Choose Cured Pharmacy for Your Weight Loss Injection Prescription

Cured Pharmacy combines clinical excellence with transparent pricing and patient-focused service. Our UK-registered clinical team provides free online consultations completed in under 3 minutes, with prescription decisions made by qualified UK prescribers who assess your individual medical needs.

We guarantee the lowest prices in the UK with upfront pricing displayed before consultation — no hidden fees or surprise charges. All medications are genuine UK-licensed products sourced through regulated channels and dispensed from our GPhC-registered pharmacy (9012511). Your treatment arrives in 100% discreet packaging with no external branding or product descriptions.

Our clinical team remains available throughout your treatment journey to answer questions, adjust dosing schedules, or address any concerns. You'll receive comprehensive patient information leaflets, injection technique guidance, and ongoing support to optimise your weight loss outcomes whilst ensuring safe medication use.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Public Assessment Report: Mounjaro 2.5 mg solution for injection in pre-filled pen. GOV.UK. [accessed 13 August 2026]
2. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. [accessed 13 August 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.